The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bertolino Arthur Peter since 2015.
The trader's CIK number is 1426344.
At the time of the last reporting, Bertolino Arthur Peter was the EVP and Chief Medical Officer of Revance Therapeutics, Inc.. (stock ticker symbol RVNC).
Also see all insider trading activities at Revance Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | RVNC | 0 | $0 | 7,753 | $304,925 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-11-17 | RVNC | Sale | 7,753 | 39.33 | 304,925 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bertolino Arthur Peter (EVP and Chief Medical Officer of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.